Skip to main content
. 2024 Jan 18;24:36. doi: 10.1186/s12935-024-03225-4

Fig. 7.

Fig. 7

Schematic diagram of this study. A patient-derived MNO model, which includes diverse cell types of the tumor microenvironment and is practicable for cryopreserving-recovery cycles, was established. Biological and genetic features were validated using diverse in vitro assays and WES. Drug screening was performed as a representative application of MNO model